disease 5,291 words KG: ent-dise-06dd4f81
Contents

Alzheimer's Disease

Disease Info
Amyloid-beta plaquesExtracellular deposits of Aβ peptides (Aβ40, Aβ42)
Neurofibrillary tanglesIntracellular tau protein aggregates (paired helical filaments)
Neuronal lossProgressive death of synapses and neurons, particularly in hippocampus and cortex
Neuroinflammationchronic activation of microglia and astrocytes; the NF-κB Signaling pathway regulates this response
Synaptic dysfunctionEarly loss of synaptic markers and function
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (190)

Vagal Afferent Microbial Signal Modulation
Score: 0.62
Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m
Score: 0.62
Sphingolipid Metabolism Reprogramming
Score: 0.62
Low Complexity Domain Cross-Linking Inhibition
Score: 0.62
Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro
Score: 0.61
Restoring Neuroprotective Tryptophan Metabolism via Targeted
Score: 0.61
Complement-Mediated Synaptic Pruning Dysregulation
Score: 0.61
The Glial Ketone Metabolic Shunt Hypothesis
Score: 0.61
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci
Score: 0.60
Glycosaminoglycan Template Disruption Approach
Score: 0.60
Brain Insulin Resistance with Glucose Transporter Dysfunctio
Score: 0.60
Netrin-1 Gradient Restoration
Score: 0.59
Tau-Independent Microtubule Stabilization via MAP6 Enhanceme
Score: 0.57
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.57
Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.57
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.56
Circadian-Gated Maresin Biosynthesis Amplification
Score: 0.56
Liquid-Liquid Phase Separation Modifier Therapy
Score: 0.55
Digital Twin-Guided Metabolic Reprogramming
Score: 0.55
Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy
Score: 0.55
← Prevpg 8/10Next →

Related Analyses (30)

SEA-AD Single-Cell Analysis: Cell-Type Vulnerability in Alzh
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived

Related Experiments (30)

CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.51
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.45
Lifestyle Intervention Mechanisms in Alzheimer's Disease
validation · proposed · Score: 0.40

See Also (15)

ASL Perfusion Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
Digital Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
Dried Blood Spot Biomarker Test for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
DTI Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
EEG Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.